Use of botulinum toxin in pediatric otolaryngology and laryngology

International Journal of Pediatric Otorhinolaryngology

Volumn 78, Issue 9, 2014, Pages 1423-1425

  Shogan, Andrea Nath ^a   Rogers, Derek J ^b   Hartnick, Christopher J ^b   Kerschner, Joseph E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Division of Pediatric Otolaryngology   (United States)

Author keywords

Botox; Paradoxical vocal fold dysfunction; Pediatric

Indexed keywords

BOTULINUM TOXIN;

ALEXANDER DISEASE; CHILD HEALTH CARE; CONGENITAL TORTICOLLIS; CRICOPHARYNGEAL ACHALASIA; CRICOPHARYNGEAL SPASM; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSE COMPARISON; DRUG EFFICACY; DYSPHAGIA; EAR NOSE THROAT DISEASE; ESTHETIC SURGERY; HUMAN; HYPERSALIVATION; LARYNX GRANULOMA; LETHARGY; MYOTOMY; OTORHINOLARYNGOLOGY; OVERACTIVE BLADDER; PALATAL MYOCLONUS; PHARYNX DISEASE; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SEIZURE; SPASMODIC DYSPHONIA; SPASTICITY; SPEECH THERAPY; TORTICOLLIS; TREATMENT OUTCOME; URINE INCONTINENCE; VOCAL CORD DISORDER; VOCAL CORD PARALYSIS; WEAKNESS; OTORHINOLARYNGOLOGIC DISEASES; PEDIATRICS; PROCEDURES;

BOTULINUM TOXINS; HUMANS; OTOLARYNGOLOGY; OTORHINOLARYNGOLOGIC DISEASES; PEDIATRICS;

EID: 84905251953     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2014.06.026     Document Type: Review

References (27)

1. Zinovy M. History and mechanism of action. Therapeutic Uses of Botulinum Toxin 2007, 1-5. Springer-Verlag, New York. G. Cooper, G. Cooper (Eds.).
2. ® (botulinum toxin type A) - purified neurotoxin complex relative to other botulinurn neurotoxin preparations. Eur. J. Neurol. 2007, 6(S4):s3-s10.
3. Lew M.F. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin. J. Pain 2002, 18(6):S142-S146.
4. Allergan Inc BOTOX Demonstrates Efficacy in Reducing Urinary Leakage Episodes 2013, Allergan Inc. Press Releases. http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=734524.
5. Blitzer A., Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2009, 111(2):218-226.
6. Blitzer A., Brin M.F., Stewart C.F. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 2009, 108(10):1435-1441.
7. Moermann M.B.J., Mieke B.J. Cricopharyngeal Botox injection: indications and technique. Curr. Opin. Otolaryngol. Head Neck Surg. 2006, 14(6):431.
8. Pascual-Pascual S.I., Pascual-Castroviejo I. Safety of botulinum toxin type A in children younger than 2 years. Eur. J. Paediatr. Neurol. 2009, 13:511-515.
9. Bhayani M.K., Suskind D.L. The use of botulinum toxin in patients with sialorrhea. Oper. Tech. Otolaryngol. Head Neck Surg. 2008, 19(4):243-247.
10. Brehert R., et al. Ultrasound-guided botulinum toxin injections for treatment of drooling. Eur. Ann. Otorhinolaryng. Head Neck Dis. 2011, 128(5):266-271.
11. Schroeder A.S., et al. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence. Neuropediatrics 2012, 43(1):27-36.
12. Chun R., Sitton M., Tipnis N.A., Arvedson J.C., Rao A., Dranove J., Brown D.J. Endoscopic Cricopharyngeal Myotomy (CPM) for Management of Cricopharyngeal Achalasia (CA) in an 18-Month-Old Child. Laryngoscope 2013, 123(3):797-800.
13. Barnes M.A., Ho A.S., Malhotra P.S., Koltai P.J., Messner A. The use of botulinum toxin for pediatric cricopharyngeal achalasia. Int. J. Pediatr. Otorhinolaryngol. 2011, 75(9):1210-1214.
14. Messner A., Ho A.S., Malhotra P.S., Koltai P.J., Barnes M.A. The use of botulinum toxin for pediatric cricopharyngeal achalasia. Int. J. Pediatr. Otorhinolaryngol. 2011, 75(6):830-834.
15. Do T.T. Congenital muscular torticollis: current concepts and review of treatment. Curr. Opin. Pediatr. 2006, 18:26-29.
16. Joyce M.B., DeChalain T.M. Treatment of recalcitrant idiopathic muscular torticollis in infants with botulinum toxin type A. J. Craniofacial. Surg. 2004, 16:321-327.
17. Sullivan M.D., Heywood B.M., Beukelman D.R. A treatment for vocal cord dysfunction in female athletes: an outcome study. Laryngoscope 2001, 111(10):1751-1755.
18. Altman K.W., Mirza N., Ruiz C., Sataloff R.T. Paradoxical vocal fold motion: presentation and treatment options. J. Voice 2000, 14(1):99-103.
19. Maturo S., Hill C., Bunting G., Baliff C., Ramakrishna J., Scirica C., Fracchia S., Donovan A., Hartnick C. Pediatric paradoxical vocal-fold motion: presentation and natural history. Pediatrics 2011, 128(6):e1443-e1449.
20. Andrade Filho P.A., Rosen C.A. Bilateral vocal fold paralysis: an unusual treatment with botulinum toxin. J. Voice 2004, 18(2):254-255.
21. El-Hakim H. Injection of botulinum toxin into external laryngeal muscles in pediatric laryngeal paralysis. Ann. Otol. Rhinol. Laryngol. 2008, 117(8):614-620.
22. Troung D.D., Rontal M., Rolnick M., Aronson A.E., Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991, 101(6 Pt 1):630-634.
23. Blitzer A., Brin M.F. Laryngeal dystonia: a series with botulinum toxin therapy. Ann. Otol. Rhinol. Laryngol. 1991, 100(2):85-89.
24. Ludlow C.L. Treatment for spasmodic dysphonia: limitations of current approaches. Curr. Opin. Otolaryngol. Head Neck Surg. 2009, 17(3):160-165.
25. Johnson A.B., Brenner M. Alexander's disease clinical, pathologic, and genetic features. J. Child Neurol. 2003, 18(9):625-632.
26. Jaroma M., Pakarinen L., Nuutinen J. Treatment of vocal cord granuloma. Acta Otolaryngol. (Stockh) 1989, 107:296-299.
27. Nasri S., Sercarz J.A., McAlpin T., Berke G.S. Treatment of vocal fold granuloma using botulinum toxin type A. Laryngoscope 1995, 105:585-588.